Olema Pharmaceuticals Names Jason O'Byrne Chief Financial Officer

PUBT · 3d ago
Olema Pharmaceuticals Names Jason O'Byrne Chief Financial Officer
  • Olema Pharmaceuticals appointed Jason O'Byrne as chief financial officer in the third quarter of 2026.
  • O'Byrne's professional background spans corporate strategy, capital markets and financial management and operations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Olema Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-454403), on November 10, 2026, and is solely responsible for the information contained therein.